SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camson Bio Technologies shines on receiving nod to hive off seeds business

05 Nov 2012 Evaluate

Camson Bio Technologies is currently trading at Rs. 60.50, up by 2.00 points or 3.42% from its previous closing of Rs. 58.50 on the BSE.

The scrip opened at Rs. 60.20 and has touched a high and low of Rs. 63.00 and Rs. 59.00 respectively. So far 3,95,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 69.50 on 08-Nov-2011 and a 52 week low of Rs. 36.50 on 04-Jun-2012.

Last one week high and low of the scrip stood at Rs. 63.00 and Rs. 57.70 respectively. The current market cap of the company is Rs. 97.00 crore.

The promoters holding in the company stood at 31.56% while Institutions and Non-Institutions held 6.34% and 62.10% respectively.

Camson Bio Technologies has received an approval for hiving off the seeds business of the company into separate wholly owned subsidiary (WOS) through prescribed procedures. The board at its meeting held on November 02, 2012 has approved for the above.

Besides, the company has also received approval for investment in a private company with synergic business objectives and to make it subsidiary of the company.

Camson Bio Technologies operates as an integrated agriculture biotechnology company in India. It produces hybrid seeds, bio-fungicides, bio-insecticides, bio-stimulants, bio-fertilizers, and biocides catering to the requirements of farmers.

Camson Bio Share Price

3.31 0.00 (0.00%)
11-May-2020 18:01 View Price Chart
Peers
Company Name CMP
Venkys India 1566.80
Mangalam Global Ent 13.86
Kaveri Seed 974.35
Regaal Resources 82.21
Simran Farms 160.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×